Piper Sandler analyst Brent Bracelin raised the firm’s price target on Procore (PCOR) to $90 from $70 and keeps an Overweight ...

Fintel reports that on November 22, 2024, Piper Sandler downgraded their outlook for Sunrun (NasdaqGS:RUN) from Overweight to ...

FORT WORTH, Texas, November 22, 2024 -- ( BUSINESS WIRE )--Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the Piper Sandler ...

In a report released yesterday, Kashy Harrison from Piper Sandler downgraded Sunrun (RUN – Research Report) to a Hold, with a price target of ...

Piper Sandler analyst Thomas Champion raised the company’s price target from $115 to $150, driven by robust advertising metrics and accelerating user growth in October.

Investing.com -- Piper Sandler on Friday downgraded the residential solar company Sunrun Inc (NASDAQ:RUN) to "neutral" from ...

TELA Bio, Inc. (NASDAQ: TELA) announced its participation in Piper Sandler’s 36th Annual Healthcare Conference, a premier ...

With nearly $3 billion in assets under management, including pending acquisitions, Abacus is the only publicly traded global alternative asset manager focused on lifespan-based financial products.

Humacyte Inc’s profitability metrics reveal financial health. The company currently boasts an operating margin of 0.00% with a gross margin of -41.67%. The profit margin, also known as the revenue ...

Piper Sandler analyst Matthew O’Brien reiterated a Buy rating on Stryker (SYK – Research Report) today and set a price target of $420.00. The ...

Wall Street has observed the benchmark S&P 500 trim some of its post-election gains as the dust settles following Donald ...